In a patient with prior tuberculosis and silicosis who has a CT‑proven aspergilloma and unilateral fine crackles, how does aspergillosis differ from an aspergilloma?

Aspergilloma vs. Aspergillosis: Key Distinctions

Aspergilloma is a specific radiological and pathological finding—a fungal ball within a cavity—while aspergillosis refers to the broader spectrum of disease processes caused by Aspergillus infection, of which aspergilloma is just one manifestation. 1

Understanding the Terminology

Aspergilloma: The Fungal Ball

An aspergilloma is not a disease entity itself, but rather a morphological feature consisting almost entirely of fungal hyphae and extracellular matrix that forms within a pre-existing pulmonary or pleural cavity 1. Key characteristics include:

• Radiological appearance: A solid, round or oval intracavitary mass partially surrounded by a crescent of air (the "air-crescent sign"), typically mobile with position changes 1
• Pathological composition: Collapsed mats of fungal growth from the interior cavity surface that coalesce into a mature fungus ball 1
• Does not enhance with intravenous contrast on CT imaging 1
• Late manifestation of chronic pulmonary aspergillosis, not an early finding 1

Aspergillosis: The Disease Spectrum

Aspergillosis encompasses multiple distinct clinical entities caused by Aspergillus species. In your patient's context (post-TB and silicosis), the relevant forms are:

Chronic Pulmonary Aspergillosis (CPA) includes several subtypes 1:

1. Simple (Single) Aspergilloma: A single fungal ball in a single cavity with minimal or no symptoms, no radiological progression over ≥3 months, and serological/microbiological evidence of Aspergillus 1

2. Chronic Cavitary Pulmonary Aspergillosis (CCPA): One or more pulmonary cavities (which may contain aspergillomas) with significant pulmonary and/or systemic symptoms, progressive disease, and evidence lasting ≥3 months 1, 2

3. Chronic Fibrosing Pulmonary Aspergillosis (CFPA): Terminal stage with extensive pulmonary fibrosis from untreated CCPA 1

Critical Diagnostic Distinctions

For Your Patient with TB/Silicosis History

The presence of an aspergilloma on CT does NOT automatically mean the patient has only "simple aspergilloma"—this is a common diagnostic pitfall 1. You must determine which form of CPA exists:

Diagnostic Algorithm:

1. Duration: Symptoms and radiological findings must be present for ≥3 months to diagnose any form of CPA 1

2. Cavity assessment:

   • Single cavity with fungal ball only = potential simple aspergilloma
   • Multiple cavities, progressive cavitation, or thick irregular cavity walls = CCPA 1

3. Symptom evaluation:

   • Minimal/no symptoms = simple aspergilloma
   • Pulmonary symptoms (cough, dyspnea, hemoptysis), weight loss, fatigue, or progressive lung function decline = CCPA 2

4. Radiological progression:

   • Stable over 6-24 months = simple aspergilloma
   • Enlarging cavities, new cavities, or increasing consolidation = CCPA 1, 2

5. Microbiological confirmation:

   • Aspergillus IgG antibody (precipitins) elevated in >90% of CPA cases—most sensitive test 1, 2
   • Sputum culture or PCR for Aspergillus (PCR more sensitive than culture) 2
   • Direct microscopy or culture from biopsy if obtained 1

Management Implications: Why the Distinction Matters

Simple Aspergilloma Management:

• Asymptomatic patients: Observe without antifungal therapy, follow every 3-6 months 2
• Symptomatic patients (especially hemoptysis): Surgical resection is recommended, preferably via video-assisted thoracic surgery 1, 2
• Perioperative antifungals generally not required unless high spillage risk 2

CCPA Management:

• Long-term oral antifungal therapy (minimum 6 months, often lifelong) with itraconazole or voriconazole 1, 2
• Cannot be cured by surgery alone due to progressive, multifocal nature 1
• Requires monitoring for drug interactions, toxicity, and therapeutic drug levels 1
• Hemoptysis managed with tranexamic acid, bronchial artery embolization, or antifungals 1, 2

Common Pitfalls in Your Clinical Scenario

Post-TB and silicosis patients are at exceptionally high risk for CCPA, not just simple aspergilloma 3, 4, 5. The presence of unilateral fine crackles suggests active parenchymal disease beyond a simple fungal ball. Key errors to avoid:

• Don't assume a visible aspergilloma means "simple aspergilloma"—assess for multiple cavities, symptoms, and progression
• Don't miss CCPA by focusing only on the fungal ball; look for thick-walled cavities, pleural thickening, and consolidation 1
• Don't confuse with TB reactivation—CPA is frequently misdiagnosed as TB relapse in this population 4
• Silicosis creates lymph node and parenchymal changes that increase TB and CPA risk even with short exposure duration 5

In your patient: The CT-proven aspergilloma plus unilateral crackles strongly suggests CCPA rather than simple aspergilloma, requiring long-term antifungal therapy rather than observation or surgery alone 1, 2.